Medication tolerance and augmentation in restless legs syndrome: the need for drug class rotation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 17105517.
- Also identified by PMC identifier 1924754.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Restless legs syndrome (RLS) is a common condition characterized by an unpleasant urge to move the legs that usually occurs at night and may interfere with sleep. The medications used most commonly to treat RLS include dopaminergic drugs (levodopa, dopamine agonists), benzodiazepines, and narcotic analgesics. We report the cases of 2 patients with RLS who illustrate the problems of tolerance (declining response over time) and augmentation (a worsening of symptoms due to ongoing treatment) that can complicate the pharmacotherapy of RLS. We discuss the optimal management of RLS and propose strategies to overcome tolerance and augmentation such as a rotational approach among agents from different classes.
Medical subject headings
- Educational Status
- Health Education
- Patient Compliance
- Restless Legs Syndrome